Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model. (Q51760100)
Jump to navigation
Jump to search
scientific article published on 21 March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model. |
scientific article published on 21 March 2007 |
Statements
Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model (English)
Justin Grant
Raquel De Souza
Christine Allen
21 March 2007